US FDA's "Safe Use" programme aims to reduce medication errors and misuse
This article was originally published in Scrip
Executive Summary
The US FDA will identify specific drugs, drug classes or therapeutic situations associated with significant, preventable harm for possible intervention under its recently announced "Safe Use" initiative.